Advertisement
UK markets close in 7 hours 23 minutes
  • FTSE 100

    8,154.80
    +33.60 (+0.41%)
     
  • FTSE 250

    20,273.70
    +79.23 (+0.39%)
     
  • AIM

    768.52
    +4.15 (+0.54%)
     
  • GBP/EUR

    1.1797
    -0.0003 (-0.03%)
     
  • GBP/USD

    1.2691
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    47,889.43
    -1,354.85 (-2.75%)
     
  • CMC Crypto 200

    1,309.39
    -25.53 (-1.91%)
     
  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     
  • DOW

    39,331.85
    +162.33 (+0.41%)
     
  • CRUDE OIL

    83.08
    +0.27 (+0.33%)
     
  • GOLD FUTURES

    2,356.40
    +23.00 (+0.99%)
     
  • NIKKEI 225

    40,580.76
    +506.07 (+1.26%)
     
  • HANG SENG

    17,982.43
    +213.29 (+1.20%)
     
  • DAX

    18,252.69
    +88.63 (+0.49%)
     
  • CAC 40

    7,599.81
    +61.52 (+0.82%)
     

CORRECTED-UPDATE 2-Walgreens books $5.8-billion impairment charge on VillageMD investment

(Corrects company name in paragraph 1, a previous version had same error)

March 28 (Reuters) - Walgreens Boots Alliance cut the higher end of its profit forecast for fiscal-year 2024 on Thursday, citing economic headwinds in its retail operations, and took a $5.8-billion impairment charge related to its VillageMD business.

VillageMD, which runs doctors' clinics, has been losing money and burning cash. Walgreens had invested $5.2 billion to become a majority shareholder in the firm in 2021.

Walgreens has also been grappling with decreased spending on personal care and beauty products by inflation-weary consumers, exacerbating the hit from waning demand for its COVID-19 vaccines and testing kits.

ADVERTISEMENT

The impairment charge dragged the pharmacy operator into a net loss of $5.9 billion for the quarter ended Feb. 29.

Shares of the company were down 2% at $20.60 in premarket trading.

On an adjusted basis, Walgreens reported earnings of $1.20 per share for the quarter, compared with analysts' average estimate of 82 cents per share, according to LSEG data.

The company now expects an adjusted profit of $3.20 to $3.35 per share for its financial year ending Aug. 31, compared to the $3.20 to $3.50 per share range it gave in January. (Reporting by Puyaan Singh and Leroy Leo in Bengaluru; Editing by Pooja Desai)